Literature DB >> 3003201

A novel immunoperoxidase procedure of using human monoclonal antibodies for the detection of cellular antigens in tissue sections.

A Imam, M M Drushella, C R Taylor.   

Abstract

A sensitive immunoperoxidase method was utilized to detect binding of human monoclonal antibodies to cellular antigens in formalin-fixed and paraffin-embedded tissue sections. The method was a 2-layer system utilizing biotin-labeled human monoclonal antibody and an avidin-biotin-horseradish peroxidase complex (ABC). A comparative study of this and a 4-layer peroxidase-antiperoxidase (PAP) staining method was made. In the PAP system, the monoclonal was followed by rabbit anti-human IgG, swine anti-rabbit IgG as the bridge-antibody and rabbit PAP complex. In both cases, the reaction was visualized by the use of aminoethylcarbazole (AEC) as chromogens. The former procedure was almost as sensitive and, most importantly eliminated an inherent problem associated with the latter namely the difficulty in distinguishing binding of the primary human monoclonal antibody from endogenous human Igs in tissue section. In addition, the 2-stage ABC procedure by comparison requires almost half the time.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3003201     DOI: 10.1016/0022-1759(86)90259-0

Source DB:  PubMed          Journal:  J Immunol Methods        ISSN: 0022-1759            Impact factor:   2.303


  2 in total

1.  Human monoclonal antibody Ha6D3, a candidate for treatment of leukaemia? In vitro reactivity of Ha6D3 with leukaemic cells and in vivo applications in a chimpanzee.

Authors:  J Harpprecht; M Jonker; H G Podzuweit; M L Hansmann; J Treumer; V Eckstein; P C van Eerd; W Müller-Ruchholtz
Journal:  Br J Cancer Suppl       Date:  1990-07

2.  Detection by a human monoclonal antibody of a glycoprotein associated with malignant proliferation of mammary epithelial cells.

Authors:  S A Imam; L A Mills; C R Taylor
Journal:  Br J Cancer       Date:  1991-12       Impact factor: 7.640

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.